Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PlexoZome Levagen Spray for Post-Exercise Knee Pain
NCT06351917Phase 4Completed
- Sponsor
- RDC Clinical
- Start
- Apr 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of palmitoylethanolamide in Knee pain, sponsored by RDC Clinical. Started Apr 2024; status: completed.
02
Drugs
palmitoylethanolamide
03
Conditions
Knee pain
Beyond the preview
Go deeper on NCT06351917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06351917.